QTTB
QTTB
NASDAQ · Biotechnology

Q32 Bio Inc

$6.36
+0.46 (+7.80%)
As of Mar 31, 3:50 PM ET ·
Financial Highlights (FY 2026)
Revenue
60.69M
Net Income
33.68M
Gross Margin
Profit Margin
55.5%
Rev Growth
+155.8%
D/E Ratio
2.29
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 64.5% 64.5% 64.5%
Operating Margin 28.5% -28.5% -30.0% -31.9%
Profit Margin 55.5% -27.8% -31.6% -27.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 60.69M 8.10M 7.51M 6.99M
Gross Profit 5.23M 4.85M 4.51M
Operating Income 17.29M -2,307,109 -2,257,916 -2,232,357
Net Income 33.68M -2,253,266 -2,377,750 -1,909,981
Gross Margin 64.5% 64.5% 64.5%
Operating Margin 28.5% -28.5% -30.0% -31.9%
Profit Margin 55.5% -27.8% -31.6% -27.3%
Rev Growth +155.8% +18.0% -0.1% +13.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 36.35M 26.39M 25.22M 27.43M
Total Equity 15.88M 33.72M 33.32M 32.74M
D/E Ratio 2.29 0.78 0.76 0.84
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 33.33M -3,375,106 -3,186,219 -2,905,098
Free Cash Flow -1,035,116 -1,228,536 -1,335,718